The use of surveillance and preventative measures for methicillin-resistant staphylococcus aureus infections in surgical patients

Antimicrobial Resistance and Infection Control

Volumn 3, Issue 1, 2014, Pages

  Kavanagh, Kevin T ^a   Calderon, Lindsay E ^b   Saman, Daniel M ^a,c   Abusalem, Said K ^a,d  

^a Health Watch USA ^*  (United States)

^b EASTERN KENTUCKY UNIVERSITY   (United States)

^c ESSENTIA INSTITUTE OF RURAL HEALTH   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; DISINFECTANT AGENT;

ANTIBIOTIC PROPHYLAXIS; COMMENSAL; DISEASE SURVEILLANCE; DRUG CHOICE; HAND WASHING; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOME; NONHUMAN; PREOPERATIVE EVALUATION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT;

EID: 84921378077     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-3-18     Document Type: Review

References (50)

1. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S,Emerging Infections Program-Active Bacterial Core Surveillance MRSA Surveillance Investigators National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013, 173(21):1970-1978. Emerging Infections Program-Active Bacterial Core Surveillance MRSA Surveillance Investigators.
2. Eisler P. Dangerous MRSA bacteria expand into communities. USA Today 2013, Accessed March 30, 2014. Available at http://www.usatoday.com/story/news/nation/2013/12/16/mrsa-infection-community-schools-victims-doctors/3991833/.
3. Kaye KS, Anderson DJ, Sloane R, Chen LF, Choi Y, Link K, Sexton DJ, Schmader KE. The effect of surgical site infection on older operative patients. J Am Geriatr Soc 2009, 57:46-54. 10.1111/j.1532-5415.2008.02053.x, 2729123, 19054183.
4. Lee BY, Bartsch SM, Wong KF, Yilmaz SL, Avery TR, Singh A, Song Y, Kim DS, Brown ST, Potter MA, Platt R, Huang SS. Simulation shows hospitals that cooperate on infection control obtain better results than hospitals acting alone. Health Aff (Millwood) 2012, 31:2295-2303. 10.1377/hlthaff.2011.0992, 3763190, 23048111.
5. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008, 197:1226-1234. 10.1086/533494, 18422434.
6. Nixon M, Jackson B, Varghese P, Jenkins D, Taylor G. Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg (Br) 2006, 88:812-817.
7. Chen AF, Chivukula S, Jacobs LJ, Tetreault MW, Lee JY. What Is the Prevalence of MRSA Colonization in Elective Spine Cases?. Clin Orthop Relat Res 2012, 470:2684-2689. 10.1007/s11999-012-2316-5, 3442011, 22441994.
8. Pofahl WE, Ramsey KM, Nobles DL, Cochran MK, Goettler C. Importance of methicillin-resistant Staphylococcus aureus eradication in carriers to prevent postoperative methicillin-resistant Staphylococcus aureus surgical site infection. Am Surg 2011, 77:27-31.
9. Ramarathnam V, De Marco B, Ortegon A, Kemp D, Luby J, Sreeramoju P. Risk factors for development of methicillin-resistant Staphylococcus aureus infection among colonized patients. Am J Infect Control 2013, 41:625-628. 10.1016/j.ajic.2012.08.005, 23290578.
10. Shukla S, Nixon M, Acharya M, Korim MT, Pandey R. Incidence of MRSA surgical-site infection in MRSA carriers in an orthopaedic trauma unit. J Bone Joint Surg (Br) 2009, 91:225-228.
11. Gupta K, Strymish J, Abi-Haidar Y, Williams SA, Itani KM. Preoperative nasal methicillin-resistant Staphylococcus aureus status, surgical prophylaxis, and risk-adjusted postoperative outcomes in veterans. Infect Control Hosp Epidemiol 2011, 32:791-796. 10.1086/660362, 21768763.
12. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 1995, 31:13-24. 10.1016/0195-6701(95)90079-9, 7499817.
13. Ziakas PD, Anagnostou T, Mylonakis E. The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU Setting: a meta-analysis of published studies. Crit Care Med 2014, 42(2):433-444. 10.1097/CCM.0b013e3182a66bb8, 24145849.
14. Lee AS, Cooper BS, Malhotra-Kumar S, Chalfine A, Daikos GL, Fankhauser C, Carevic B, Lemmen S, Martinez JA, Masuet-Aumatell C, Pan A, Phillips G, Rubinovitch B, Goossens H, Brun-Buisson C, Harbarth S,for the MOSAR WP4 Study Group Comparison of strategies to reduce methicillin resistant Staphylococcus aureus rates in surgical patients: a controlled multicenter intervention trial. BMJ Open 2013, 3:e003126. 3780302, 24056477, for the MOSAR WP4 Study Group.
15. Rao N, Cannella B, Crossett LS, Yates AJ, McGough R. A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008, 466:1343-1348. 10.1007/s11999-008-0225-4, 2384036, 18404296.
16. Glick SB, Samson DJ, Huang E, Vats V, Weber S, Aronson N. Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA). Comparative Effectiveness Reviews, No. 102 2013, 13-EHC043-EF. Rockville (MD): Agency for Healthcare Research and Quality (US).
17. Malde DJ, Abidia A, McCollum C, Welch M. The success of routine MRSA screening in vascular surgery: a nine year review. Int Angiol 2006, 25:204-208.
18. Lipke VL, Hyott AS. Reducing surgical site infections by bundling multiple risk reduction strategies and active surveillance. AORN J 2010, 92:288-296. 10.1016/j.aorn.2010.01.016, 20816102.
19. Kavanagh KT, Saman DM, Yu Y. A Perspective on How the United States Fell Behind Northern Europe in the Battle Against Methicillin Resistant Staphylococcus Aureus. Antimicrob Agents Chemother 2013, 57:5789-5791. 10.1128/AAC.01839-13, 3837914, 24100502.
20. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, Renzi G, Vernaz N, Sax H, Pittet D. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157. 10.1001/jama.299.10.1149, 18334690.
21. U. S. House of Representatives Healthcare-associated infections: a preventable epidemic. Hearing before the Committee on Oversight and Government Reform, House of Representatives Washington, DC: U.S. House of Representatives, Accessed March 30, 2014. Available at http://oversight-archive.waxman.house.gov/documents/20080416111629.pdf, U. S. House of Representatives.
22. Letter EF. Assistant Press Secretary, Henry Waxman, E-Mail February 2, 2012. Accessed March 30, 2014. Available at http://www.healthwatchusa.org/publications/2012-Documents/20120202-Waxman-HAI-Hearing.pdf.
23. Cohen AL, Calfee D, Fridkin SK, Huang SS, Jernigan JA, Lautenbach E, Oriola S, Ramsey KM, Salgado CD, Weinstein RA,Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol 2008, 29:901-913. 10.1086/591741, 18808340, Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee.
24. GAO Health-Care-Associated Infections in Hospitals: Leadership Needed from HHS to Prioritize Prevention Practices and Improve Data on These Infections, GAO-08-283. 2008, Washington, DC: , Accessed March 30, 2014. Available at http://www.gao.gov/cgi-bin/getrpt?GAO-08-283, GAO.
25. Drees M, Pineles L, Harris AD, Morgan DJ. Variation in definitions and isolation procedures for multidrug-resistant gram-negative bacteria: a survey of the society for healthcare epidemiology of America research network. Infect Control Hosp Epidemiol 2014, 35:362-366. 10.1086/675600, 24602940.
26. Sott AH, Jones R, Davies S, Cumberland N. The value of pre-operative screening for MRSA in the reduction of sepsis in total hip replacement associated with MRSA. A prospective audit. HIP Int 2001, 11:102-106.
27. Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, Hunter DJ, Martha JF, Miley GB, Parazin SJ, Dejoie P, Richmond JC. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am 2010, 92:1820-1826. 10.2106/JBJS.I.01050, 20610773.
28. Thomas S, Cantrill S, Waghorn DJ, McIntyre A. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther 2007, 25:593-597. 10.1111/j.1365-2036.2006.03242.x, 17305760.
29. Jog S, Cunningham R, Cooper S, Wallis M, Marchbank A, Vasco-Knight P, Jenks PJ. Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect 2008, 69:124-130. 10.1016/j.jhin.2008.02.008, 18387695.
30. Sankar B, Hopgood P, Bell KM. The role of MRSA screening in joint-replacement surgery. Int Orthop 2005, 29:160-163. 10.1007/s00264-005-0649-3, 3456888, 15864590.
31. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med 2011, 171:68-73.
32. Crawford T, Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis?. Clin Infect Dis 2012, 54:1474-1479. 10.1093/cid/cis027, 22328468.
33. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9-17. 10.1056/NEJMoa0808939, 20054045.
34. National Health Service, Screening for Meticillin-resistant Staphylococcus aureus (MRSA) colonisation A strategy for NHS trusts: a summary of best practice. Accessed March 25, 2014. Available at http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_063187.pdf, National Health Service, Screening for Meticillin-resistant Staphylococcus aureus (MRSA) colonisation.
35. Center for Disease Dynamics, Economics & Policy First reported cases of bacterial resistance against key antibiotics. Accessed March 25, 2014. Available at http://cddep.org/tools/first_reported_cases_bacterial_resistance_against_key_antibiotics, Center for Disease Dynamics, Economics & Policy.
36. McDanel JS, Murphy CR, Diekema DJ, Quan V, Kim DS, Peterson EM, Evans KD, Tan GL, Hayden MK, Huang SS. Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother 2013, 57:552-558. 10.1128/AAC.01623-12, 3535956, 23147721.
37. Derde LP, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJ, Gniadkowski M, Hyrniewicz W, Empel J, Dautzenberg MJ, Annane D, Aragão I, Chalfine A, Dumpis U, Esteves F, Giamarellou H, Muzlovic I, Nardi G, Petrikkos GL, Tomic V, Martí AT, Stammet P, Brun-Buisson C, Bonten MJ,on behalf of the MOSAR WP3 Study Team Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014, 14:31-39. 10.1016/S1473-3099(13)70295-0, 3895323, 24161233, on behalf of the MOSAR WP3 Study Team.
38. Rotter ML, Larsen SO, Cooke EM, Dankert J, Daschner F, Greco D, Grönross P, Jepsen OB, Lystad A, Nyström B. A comparison of the effects of preoperative whole-body bathing with detergent alone and with detergent containing chlorhexidine gluconate on the frequency of wound infections after clean surgery. The European Working Party on Control of Hospital Infections. J Hosp Infect 1988, 11:310-320. 10.1016/0195-6701(88)90083-7, 2899582.
39. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R,the CDC Prevention Epicenters Program; the AHRQ DECIDE Network and Healthcare-Associated Infections Program Targeted versus Universal Decolonization to Prevent ICU Infection. N Engl J Med 2013, 368:2255-2265. 10.1056/NEJMoa1207290, 23718152, the CDC Prevention Epicenters Program; the AHRQ DECIDE Network and Healthcare-Associated Infections Program.
40. ClinicalTrials.gov, National Institutes of Health Changes to Changes to NCT00980980 on 2013_10_16. Accessed March 31, 2014. Available at http://clinicaltrials.gov/archive/NCT00980980/2013_10_16/changes, ClinicalTrials.gov, National Institutes of Health.
41. Lee AS, Macedo-Vinas M, François P, Renzi G, Schrenzel J, Vernaz N, Pittet D, Harbarth S. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011, 52:1422-1430. 10.1093/cid/cir233, 21628482.
42. Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2013, 4:137-142.
43. Kelley ST, Gilbert J. Studying the microbiology of the indoor environment. Genome Biol 2013, 14:202. 10.1186/gb-2013-14-2-202, 3663111, 23514020.
44. Bokulich NA, Mills DA. Facility-specific " house" microbiome drives microbial landscapes of artisan cheesemaking plants. Appl Environ Microbiol 2013, 79:5214-5223. 10.1128/AEM.00934-13, 3753952, 23793641.
45. Horner C, Mawer D, Wilcox M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?. J Antimicrob Chemother 2012, 67:2547-2559. 10.1093/jac/dks284, 22833635.
46. Naparstek L, Carmeli Y, Chmelnitsky I, Banin E, Navon-Venezia S. Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae. J Hosp Infect 2012, 81:15-19. 10.1016/j.jhin.2012.02.007, 22463977.
47. Rineh A, Kelso MJ, Vatansever F, Tegos GP, Hamblin MR. Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther 2014, 12:131-150. 10.1586/14787210.2014.866515, 24410618.
48. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 2003, 149:530-534. 10.1046/j.1365-2133.2003.05552.x, 14510985.
49. Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 2014, 26:101-107. 10.1097/BOR.0000000000000008, 24247114.
50. U.S. Preventive Services Task Force Grade Definitions. Accessed November 18, 2013. Available at http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm, U.S. Preventive Services Task Force.